<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-05-30" modified="2020-10-07" version="192">
<accession>O14746</accession>
<accession>O14783</accession>
<accession>Q2XS35</accession>
<accession>Q8N6C3</accession>
<accession>Q8NG38</accession>
<accession>Q8NG46</accession>
<name>TERT_HUMAN</name>
<protein>
<recommendedName>
<fullName>Telomerase reverse transcriptase</fullName>
<ecNumber evidence="37 45">2.7.7.49</ecNumber>
</recommendedName>
<alternativeName>
<fullName>HEST2</fullName>
</alternativeName>
<alternativeName>
<fullName>Telomerase catalytic subunit</fullName>
</alternativeName>
<alternativeName>
<fullName>Telomerase-associated protein 2</fullName>
<shortName>TP2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">TERT</name>
<name type="synonym">EST2</name>
<name type="synonym">TCS1</name>
<name type="synonym">TRT</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Cell" volume="90" first="785" last="795">
<title>hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.</title>
<authorList>
<person name="Meyerson M."/>
<person name="Counter C.M."/>
<person name="Eaton E.N."/>
<person name="Ellisen L.W."/>
<person name="Steiner P."/>
<person name="Caddle S.D."/>
<person name="Ziaugra L."/>
<person name="Beijersbergen R.L."/>
<person name="Davidoff M.J."/>
<person name="Liu Q."/>
<person name="Bacchetti S."/>
<person name="Haber D.A."/>
<person name="Weinberg R.A."/>
</authorList>
<dbReference type="PubMed" id="9288757"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80538-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Science" volume="277" first="955" last="959">
<title>Telomerase catalytic subunit homologs from fission yeast and human.</title>
<authorList>
<person name="Nakamura T.M."/>
<person name="Morin G.B."/>
<person name="Chapman K.B."/>
<person name="Weinrich S.L."/>
<person name="Andrews W.H."/>
<person name="Lingner J."/>
<person name="Harley C.B."/>
<person name="Cech T.R."/>
</authorList>
<dbReference type="PubMed" id="9252327"/>
<dbReference type="DOI" id="10.1126/science.277.5328.955"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Gene" volume="232" first="97" last="106">
<title>Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT).</title>
<authorList>
<person name="Wick M."/>
<person name="Zubov D."/>
<person name="Hagen G."/>
</authorList>
<dbReference type="PubMed" id="10333526"/>
<dbReference type="DOI" id="10.1016/s0378-1119(99)00108-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Neoplasia" volume="5" first="193" last="197">
<title>Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene.</title>
<authorList>
<person name="Hisatomi H."/>
<person name="Ohyashiki K."/>
<person name="Ohyashiki J.H."/>
<person name="Nagao K."/>
<person name="Kanamaru T."/>
<person name="Hirata H."/>
<person name="Hibi N."/>
<person name="Tsukada Y."/>
</authorList>
<dbReference type="PubMed" id="12869302"/>
<dbReference type="DOI" id="10.1016/s1476-5586(03)80051-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Oncol. Rep." volume="11" first="127" last="131">
<title>Differential alternative splicing expressions of telomerase reverse transcriptase in gastrointestinal cell lines.</title>
<authorList>
<person name="Nagao K."/>
<person name="Katsumata K."/>
<person name="Aizawa Y."/>
<person name="Saito N."/>
<person name="Hirata H."/>
<person name="Sasaki H."/>
<person name="Yamamoto S."/>
<person name="Hikiji K."/>
<person name="Koiwa T."/>
<person name="Hisatomi H."/>
</authorList>
<dbReference type="PubMed" id="14654914"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4)</scope>
<source>
<tissue>Stomach cancer</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2001-10" db="EMBL/GenBank/DDBJ databases">
<title>Sequence of a BAC carrying the entire hTERT gene.</title>
<authorList>
<person name="Londono-Vallejo J.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS TYR-412 AND THR-1062</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1996" name="J. Exp. Med." volume="183" first="2471" last="2479">
<title>Regulated expression of telomerase activity in human T lymphocyte development and activation.</title>
<authorList>
<person name="Weng N.P."/>
<person name="Levine B.L."/>
<person name="June C.H."/>
<person name="Hodes R.J."/>
</authorList>
<dbReference type="PubMed" id="8676067"/>
<dbReference type="DOI" id="10.1084/jem.183.6.2471"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="Genes Dev." volume="11" first="3109" last="3115">
<title>Human telomerase contains evolutionarily conserved catalytic and structural subunits.</title>
<authorList>
<person name="Harrington L."/>
<person name="Zhou W."/>
<person name="McPhail T."/>
<person name="Oulton R."/>
<person name="Yeung D.S."/>
<person name="Mar V."/>
<person name="Bass M.B."/>
<person name="Robinson M.O."/>
</authorList>
<dbReference type="PubMed" id="9389643"/>
<dbReference type="DOI" id="10.1101/gad.11.23.3109"/>
</citation>
<scope>FUNCTION IN TELOMERASE ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>ASSOCIATION WITH TEP1</scope>
<scope>MUTAGENESIS OF ASP-712; ASP-868 AND ASP-869</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Curr. Biol." volume="8" first="177" last="180">
<title>Reconstitution of human telomerase activity in vitro.</title>
<authorList>
<person name="Beattie T.L."/>
<person name="Zhou W."/>
<person name="Robinson M.O."/>
<person name="Harrington L."/>
</authorList>
<dbReference type="PubMed" id="9443919"/>
<dbReference type="DOI" id="10.1016/s0960-9822(98)70067-3"/>
</citation>
<scope>RECONSTITUTION OF THE TELOMERASE COMPLEX</scope>
<scope>MUTAGENESIS OF ASP-712; ASP-868 AND ASP-869</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Mol. Biol. Cell" volume="11" first="3329" last="3340">
<title>Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding.</title>
<authorList>
<person name="Beattie T.L."/>
<person name="Zhou W."/>
<person name="Robinson M.O."/>
<person name="Harrington L."/>
</authorList>
<dbReference type="PubMed" id="11029039"/>
<dbReference type="DOI" id="10.1091/mbc.11.10.3329"/>
</citation>
<scope>ASSOCIATION WITH TEP1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="15571" last="15574">
<title>Stable association of hsp90 and p23, but Not hsp70, with active human telomerase.</title>
<authorList>
<person name="Forsythe H.L."/>
<person name="Jarvis J.L."/>
<person name="Turner J.W."/>
<person name="Elmore L.W."/>
<person name="Holt S.E."/>
</authorList>
<dbReference type="PubMed" id="11274138"/>
<dbReference type="DOI" id="10.1074/jbc.c100055200"/>
</citation>
<scope>INTERACTION WITH HSPA1A; HSP90A AND PTGES3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="4598" last="4610">
<title>Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707.</title>
<authorList>
<person name="Haendeler J."/>
<person name="Hoffmann J."/>
<person name="Brandes R.P."/>
<person name="Zeiher A.M."/>
<person name="Dimmeler S."/>
</authorList>
<dbReference type="PubMed" id="12808100"/>
<dbReference type="DOI" id="10.1128/mcb.23.13.4598-4610.2003"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-707</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH RAN AND XP01</scope>
<scope>MUTAGENESIS OF TYR-707</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="316" first="1116" last="1123">
<title>Human MCRS2, a cell-cycle-dependent protein, associates with LPTS/PinX1 and reduces the telomere length.</title>
<authorList>
<person name="Song H."/>
<person name="Li Y."/>
<person name="Chen G."/>
<person name="Xing Z."/>
<person name="Zhao J."/>
<person name="Yokoyama K.K."/>
<person name="Li T."/>
<person name="Zhao M."/>
</authorList>
<dbReference type="PubMed" id="15044100"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.02.166"/>
</citation>
<scope>INTERACTION WITH MCRS1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Circ. Res." volume="94" first="768" last="775">
<title>Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells.</title>
<authorList>
<person name="Haendeler J."/>
<person name="Hoffmann J."/>
<person name="Diehl J.F."/>
<person name="Vasa M."/>
<person name="Spyridopoulos I."/>
<person name="Zeiher A.M."/>
<person name="Dimmeler S."/>
</authorList>
<dbReference type="PubMed" id="14963003"/>
<dbReference type="DOI" id="10.1161/01.res.0000121104.05977.f3"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Histochem. Cell Biol." volume="121" first="391" last="397">
<title>Immunohistochemical localization of hTERT protein in human tissues.</title>
<authorList>
<person name="Yan P."/>
<person name="Benhattar J."/>
<person name="Seelentag W."/>
<person name="Stehle J.C."/>
<person name="Bosman F.T."/>
</authorList>
<dbReference type="PubMed" id="15138842"/>
<dbReference type="DOI" id="10.1007/s00418-004-0645-5"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="51508" last="51515">
<title>Nucleolin interacts with telomerase.</title>
<authorList>
<person name="Khurts S."/>
<person name="Masutomi K."/>
<person name="Delgermaa L."/>
<person name="Arai K."/>
<person name="Oishi N."/>
<person name="Mizuno H."/>
<person name="Hayashi N."/>
<person name="Hahn W.C."/>
<person name="Murakami S."/>
</authorList>
<dbReference type="PubMed" id="15371412"/>
<dbReference type="DOI" id="10.1074/jbc.m407643200"/>
</citation>
<scope>INTERACTION WITH NCL</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="3720" last="3733">
<title>Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.</title>
<authorList>
<person name="Moriarty T.J."/>
<person name="Marie-Egyptienne D.T."/>
<person name="Autexier C."/>
</authorList>
<dbReference type="PubMed" id="15082768"/>
<dbReference type="DOI" id="10.1128/mcb.24.9.3720-3733.2004"/>
</citation>
<scope>FUNCTIONAL DOMAINS</scope>
<scope>MUTAGENESIS OF TRP-547 AND ASP-868</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Genes Dev." volume="19" first="776" last="781">
<title>Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT.</title>
<authorList>
<person name="Kim J.H."/>
<person name="Park S.-M."/>
<person name="Kang M.R."/>
<person name="Oh S.-Y."/>
<person name="Lee T.H."/>
<person name="Muller M.T."/>
<person name="Chung I.K."/>
</authorList>
<dbReference type="PubMed" id="15805468"/>
<dbReference type="DOI" id="10.1101/gad.1289405"/>
</citation>
<scope>INTERACTION WITH MKRN1</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Mol. Biol. Cell" volume="16" first="3152" last="3161">
<title>An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization.</title>
<authorList>
<person name="Moriarty T.J."/>
<person name="Ward R.J."/>
<person name="Taboski M.A."/>
<person name="Autexier C."/>
</authorList>
<dbReference type="PubMed" id="15857955"/>
<dbReference type="DOI" id="10.1091/mbc.e05-02-0148"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-868</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="Biochem. Biophys. Res. Commun." volume="350" first="796" last="802">
<title>Telomerase with mutated catalytic motifs has dominant negative effects on telomerase activity and inhibits cell growth.</title>
<authorList>
<person name="Rahman R."/>
<person name="Mo L."/>
<person name="Cui W."/>
</authorList>
<dbReference type="PubMed" id="17026956"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2006.09.125"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ARG-631; ASP-712 AND ASP-868</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="J. Immunol." volume="178" first="7710" last="7719">
<title>The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation.</title>
<authorList>
<person name="Plunkett F.J."/>
<person name="Franzese O."/>
<person name="Finney H.M."/>
<person name="Fletcher J.M."/>
<person name="Belaramani L.L."/>
<person name="Salmon M."/>
<person name="Dokal I."/>
<person name="Webster D."/>
<person name="Lawson A.D."/>
<person name="Akbar A.N."/>
</authorList>
<dbReference type="PubMed" id="17548608"/>
<dbReference type="DOI" id="10.4049/jimmunol.178.12.7710"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="Mol. Cell" volume="28" first="773" last="785">
<title>Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation.</title>
<authorList>
<person name="Fu D."/>
<person name="Collins K."/>
</authorList>
<dbReference type="PubMed" id="18082603"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.09.023"/>
</citation>
<scope>INTERACTION WITH NAT10</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="3226" last="3240">
<title>Characterization of physical and functional anchor site interactions in human telomerase.</title>
<authorList>
<person name="Wyatt H.D."/>
<person name="Lobb D.A."/>
<person name="Beattie T.L."/>
</authorList>
<dbReference type="PubMed" id="17296728"/>
<dbReference type="DOI" id="10.1128/mcb.02368-06"/>
</citation>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF 137-TRP--LEU-141; ASP-712 AND 930-TRP--LEU-934</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="Nucleic Acids Res." volume="35" first="1155" last="1168">
<title>The active site residue Valine 867 in human telomerase reverse transcriptase influences nucleotide incorporation and fidelity.</title>
<authorList>
<person name="Drosopoulos W.C."/>
<person name="Prasad V.R."/>
</authorList>
<dbReference type="PubMed" id="17264120"/>
<dbReference type="DOI" id="10.1093/nar/gkm002"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LEU-866 AND VAL-867</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="33155" last="33161">
<title>Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase.</title>
<authorList>
<person name="Jakob S."/>
<person name="Schroeder P."/>
<person name="Lukosz M."/>
<person name="Buchner N."/>
<person name="Spyridopoulos I."/>
<person name="Altschmied J."/>
<person name="Haendeler J."/>
</authorList>
<dbReference type="PubMed" id="18829466"/>
<dbReference type="DOI" id="10.1074/jbc.m805138200"/>
</citation>
<scope>INTERACTION WITH PTPN11</scope>
<scope>PHOSPHORYLATION AT TYR-707</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-707</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Clin. Cancer Res." volume="15" first="914" last="923">
<title>Ionizing radiation up-regulates telomerase activity in cancer cell lines by post-translational mechanism via ras/phosphatidylinositol 3-kinase/Akt pathway.</title>
<authorList>
<person name="Ram R."/>
<person name="Uziel O."/>
<person name="Eldan O."/>
<person name="Fenig E."/>
<person name="Beery E."/>
<person name="Lichtenberg S."/>
<person name="Nordenberg Y."/>
<person name="Lahav M."/>
</authorList>
<dbReference type="PubMed" id="19188162"/>
<dbReference type="DOI" id="10.1158/1078-0432.ccr-08-0792"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="2613" last="2622">
<title>PML-IV functions as a negative regulator of telomerase by interacting with TERT.</title>
<authorList>
<person name="Oh W."/>
<person name="Ghim J."/>
<person name="Lee E.W."/>
<person name="Yang M.R."/>
<person name="Kim E.T."/>
<person name="Ahn J.H."/>
<person name="Song J."/>
</authorList>
<dbReference type="PubMed" id="19567472"/>
<dbReference type="DOI" id="10.1242/jcs.048066"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PML</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Nature" volume="460" first="66" last="72">
<title>Telomerase modulates Wnt signalling by association with target gene chromatin.</title>
<authorList>
<person name="Park J.I."/>
<person name="Venteicher A.S."/>
<person name="Hong J.Y."/>
<person name="Choi J."/>
<person name="Jun S."/>
<person name="Shkreli M."/>
<person name="Chang W."/>
<person name="Meng Z."/>
<person name="Cheung P."/>
<person name="Ji H."/>
<person name="McLaughlin M."/>
<person name="Veenstra T.D."/>
<person name="Nusse R."/>
<person name="McCrea P.D."/>
<person name="Artandi S.E."/>
</authorList>
<dbReference type="PubMed" id="19571879"/>
<dbReference type="DOI" id="10.1038/nature08137"/>
</citation>
<scope>INTERACTION WITH SMARCA4</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E7176" last="E7176">
<title>Human telomerase reverse transcriptase (hTERT) Q169 is essential for telomerase function in vitro and in vivo.</title>
<authorList>
<person name="Wyatt H.D."/>
<person name="Tsang A.R."/>
<person name="Lobb D.A."/>
<person name="Beattie T.L."/>
</authorList>
<dbReference type="PubMed" id="19777057"/>
<dbReference type="DOI" id="10.1371/journal.pone.0007176"/>
</citation>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF GLN-169</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Science" volume="323" first="644" last="648">
<title>A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.</title>
<authorList>
<person name="Venteicher A.S."/>
<person name="Abreu E.B."/>
<person name="Meng Z."/>
<person name="McCann K.E."/>
<person name="Terns R.M."/>
<person name="Veenstra T.D."/>
<person name="Terns M.P."/>
<person name="Artandi S.E."/>
</authorList>
<dbReference type="PubMed" id="19179534"/>
<dbReference type="DOI" id="10.1126/science.1165357"/>
</citation>
<scope>IDENTIFICATION IN THE TELOMERASE HOLOENZYME COMPLEX</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="2775" last="2786">
<title>Specificity and stoichiometry of subunit interactions in the human telomerase holoenzyme assembled in vivo.</title>
<authorList>
<person name="Egan E.D."/>
<person name="Collins K."/>
</authorList>
<dbReference type="PubMed" id="20351177"/>
<dbReference type="DOI" id="10.1128/mcb.00151-10"/>
</citation>
<scope>IDENTIFICATION IN THE TELOMERASE HOLOENZYME COMPLEX</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="Nucleic Acids Res." volume="39" first="9390" last="9404">
<title>The DEAH-box RNA helicase RHAU binds an intramolecular RNA G-quadruplex in TERC and associates with telomerase holoenzyme.</title>
<authorList>
<person name="Lattmann S."/>
<person name="Stadler M.B."/>
<person name="Vaughn J.P."/>
<person name="Akman S.A."/>
<person name="Nagamine Y."/>
</authorList>
<dbReference type="PubMed" id="21846770"/>
<dbReference type="DOI" id="10.1093/nar/gkr630"/>
</citation>
<scope>INTERACTION WITH DHX36</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2012" name="Biochem. Biophys. Res. Commun." volume="417" first="1086" last="1092">
<title>The AAA-ATPase NVL2 is a telomerase component essential for holoenzyme assembly.</title>
<authorList>
<person name="Her J."/>
<person name="Chung I.K."/>
</authorList>
<dbReference type="PubMed" id="22226966"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2011.12.101"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH NVL</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2012" name="J. Cell Sci." volume="125" first="2684" last="2697">
<title>Nuclear import of hTERT requires a bipartite nuclear localization signal and Akt-mediated phosphorylation.</title>
<authorList>
<person name="Chung J."/>
<person name="Khadka P."/>
<person name="Chung I.K."/>
</authorList>
<dbReference type="PubMed" id="22366458"/>
<dbReference type="DOI" id="10.1242/jcs.099267"/>
</citation>
<scope>PHOSPHORYLATION AT SER-227</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="7252" last="7262">
<title>Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation.</title>
<authorList>
<person name="Jung H.Y."/>
<person name="Wang X."/>
<person name="Jun S."/>
<person name="Park J.I."/>
</authorList>
<dbReference type="PubMed" id="23362280"/>
<dbReference type="DOI" id="10.1074/jbc.m112.416792"/>
</citation>
<scope>PHOSPHORYLATION AT SER-457</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-457</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="15474" last="15480">
<title>HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.</title>
<authorList>
<person name="Wang X."/>
<person name="Singh S."/>
<person name="Jung H.Y."/>
<person name="Yang G."/>
<person name="Jun S."/>
<person name="Sastry K.J."/>
<person name="Park J.I."/>
</authorList>
<dbReference type="PubMed" id="23612978"/>
<dbReference type="DOI" id="10.1074/jbc.m112.416735"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2013" name="Science" volume="339" first="959" last="961">
<title>TERT promoter mutations in familial and sporadic melanoma.</title>
<authorList>
<person name="Horn S."/>
<person name="Figl A."/>
<person name="Rachakonda P.S."/>
<person name="Fischer C."/>
<person name="Sucker A."/>
<person name="Gast A."/>
<person name="Kadel S."/>
<person name="Moll I."/>
<person name="Nagore E."/>
<person name="Hemminki K."/>
<person name="Schadendorf D."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="23348503"/>
<dbReference type="DOI" id="10.1126/science.1230062"/>
</citation>
<scope>INVOLVEMENT IN CMM9</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2018" name="Nucleic Acids Res." volume="46" first="4487" last="4504">
<title>ATF7 mediates TNF-alpha-induced telomere shortening.</title>
<authorList>
<person name="Maekawa T."/>
<person name="Liu B."/>
<person name="Nakai D."/>
<person name="Yoshida K."/>
<person name="Nakamura K.I."/>
<person name="Yasukawa M."/>
<person name="Koike M."/>
<person name="Takubo K."/>
<person name="Chatton B."/>
<person name="Ishikawa F."/>
<person name="Masutomi K."/>
<person name="Ishii S."/>
</authorList>
<dbReference type="PubMed" id="29490055"/>
<dbReference type="DOI" id="10.1093/nar/gky155"/>
</citation>
<scope>INTERACTION WITH ATF7</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2006" name="Eur. J. Immunol." volume="36" first="170" last="179">
<title>Crystal structure of HLA-A*2402 complexed with a telomerase peptide.</title>
<authorList>
<person name="Cole D.K."/>
<person name="Rizkallah P.J."/>
<person name="Gao F."/>
<person name="Watson N.I."/>
<person name="Boulter J.M."/>
<person name="Bell J.I."/>
<person name="Sami M."/>
<person name="Gao G.F."/>
<person name="Jakobsen B.K."/>
</authorList>
<dbReference type="PubMed" id="16323248"/>
<dbReference type="DOI" id="10.1002/eji.200535424"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 461-469 IN COMPLEX WITH CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX (MHC)</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2018" name="Nature" volume="557" first="190" last="195">
<title>Cryo-EM structure of substrate-bound human telomerase holoenzyme.</title>
<authorList>
<person name="Nguyen T.H.D."/>
<person name="Tam J."/>
<person name="Wu R.A."/>
<person name="Greber B.J."/>
<person name="Toso D."/>
<person name="Nogales E."/>
<person name="Collins K."/>
</authorList>
<dbReference type="PubMed" id="29695869"/>
<dbReference type="DOI" id="10.1038/s41586-018-0062-x"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (7.7 ANGSTROMS) OF THE TELOMERASE HOLOENZYME COMPLEX</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2005" name="Blood Cells Mol. Dis." volume="34" first="257" last="263">
<title>Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.</title>
<authorList>
<person name="Vulliamy T.J."/>
<person name="Walne A."/>
<person name="Baskaradas A."/>
<person name="Mason P.J."/>
<person name="Marrone A."/>
<person name="Dokal I."/>
</authorList>
<dbReference type="PubMed" id="15885610"/>
<dbReference type="DOI" id="10.1016/j.bcmd.2004.12.008"/>
</citation>
<scope>VARIANT AA THR-202</scope>
<scope>VARIANTS DKCA2 TRP-979 AND LEU-1127</scope>
<scope>CHARACTERIZATION OF VARIANT AA THR-202</scope>
<scope>CHARACTERIZATION OF VARIANTS DKCA2 TRP-979 AND LEU-1127</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2005" name="N. Engl. J. Med." volume="352" first="1413" last="1424">
<title>Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.</title>
<authorList>
<person name="Yamaguchi H."/>
<person name="Calado R.T."/>
<person name="Ly H."/>
<person name="Kajigaya S."/>
<person name="Baerlocher G.M."/>
<person name="Chanock S.J."/>
<person name="Lansdorp P.M."/>
<person name="Young N.S."/>
</authorList>
<dbReference type="PubMed" id="15814878"/>
<dbReference type="DOI" id="10.1056/nejmoa042980"/>
</citation>
<scope>VARIANTS PFBMFT1 THR-202; TYR-412; MET-694; CYS-772 AND MET-1090</scope>
<scope>VARIANTS THR-279; GLU-441 DEL AND THR-1062</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="15960" last="15964">
<title>Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.</title>
<authorList>
<person name="Armanios M."/>
<person name="Chen J.-L."/>
<person name="Chang Y.-P.C."/>
<person name="Brodsky R.A."/>
<person name="Hawkins A."/>
<person name="Griffin C.A."/>
<person name="Eshleman J.R."/>
<person name="Cohen A.R."/>
<person name="Chakravarti A."/>
<person name="Hamosh A."/>
<person name="Greider C.W."/>
</authorList>
<dbReference type="PubMed" id="16247010"/>
<dbReference type="DOI" id="10.1073/pnas.0508124102"/>
</citation>
<scope>VARIANT DKCA2 ASN-902</scope>
<scope>CHARACTERIZATION OF VARIANT DKCA2 ASN-902</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2006" name="Biochem. Biophys. Res. Commun." volume="348" first="669" last="672">
<title>Coronary artery disease and a functional polymorphism of hTERT.</title>
<authorList>
<person name="Matsubara Y."/>
<person name="Murata M."/>
<person name="Watanabe K."/>
<person name="Saito I."/>
<person name="Miyaki K."/>
<person name="Omae K."/>
<person name="Ishikawa M."/>
<person name="Matsushita K."/>
<person name="Iwanaga S."/>
<person name="Ogawa S."/>
<person name="Ikeda Y."/>
</authorList>
<dbReference type="PubMed" id="16890917"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2006.07.103"/>
</citation>
<scope>INVOLVEMENT IN CAD SUSCEPTIBILITY</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2006" name="Blood" volume="107" first="2680" last="2685">
<title>Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.</title>
<authorList>
<person name="Vulliamy T.J."/>
<person name="Marrone A."/>
<person name="Knight S.W."/>
<person name="Walne A."/>
<person name="Mason P.J."/>
<person name="Dokal I."/>
</authorList>
<dbReference type="PubMed" id="16332973"/>
<dbReference type="DOI" id="10.1182/blood-2005-07-2622"/>
</citation>
<scope>VARIANT DKCB4 ARG-721</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2006" name="Haematologica" volume="91" first="656" last="658">
<title>Mutations in telomerase catalytic protein in Japanese children with aplastic anemia.</title>
<authorList>
<person name="Liang J."/>
<person name="Yagasaki H."/>
<person name="Kamachi Y."/>
<person name="Hama A."/>
<person name="Matsumoto K."/>
<person name="Kato K."/>
<person name="Kudo K."/>
<person name="Kojima S."/>
</authorList>
<dbReference type="PubMed" id="16627250"/>
</citation>
<scope>VARIANTS AA ASP-682 AND MET-726</scope>
<scope>CHARACTERIZATION OF VARIANT AA MET-726</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2007" name="Blood" volume="109" first="524" last="532">
<title>Functional characterization of natural telomerase mutations found in patients with hematologic disorders.</title>
<authorList>
<person name="Xin Z.T."/>
<person name="Beauchamp A.D."/>
<person name="Calado R.T."/>
<person name="Bradford J.W."/>
<person name="Regal J.A."/>
<person name="Shenoy A."/>
<person name="Liang Y."/>
<person name="Lansdorp P.M."/>
<person name="Young N.S."/>
<person name="Ly H."/>
</authorList>
<dbReference type="PubMed" id="16990594"/>
<dbReference type="DOI" id="10.1182/blood-2006-07-035089"/>
</citation>
<scope>VARIANT AA ASN-570</scope>
<scope>CHARACTERIZATION OF VARIANTS ASN-570; ASP-682; ARG-721; MET-726; ASN-902; TRP-979 AND LEU-1127</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2007" name="Blood" volume="110" first="4198" last="4205">
<title>Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.</title>
<authorList>
<person name="Marrone A."/>
<person name="Walne A."/>
<person name="Tamary H."/>
<person name="Masunari Y."/>
<person name="Kirwan M."/>
<person name="Beswick R."/>
<person name="Vulliamy T."/>
<person name="Dokal I."/>
</authorList>
<dbReference type="PubMed" id="17785587"/>
<dbReference type="DOI" id="10.1182/blood-2006-12-062851"/>
</citation>
<scope>VARIANTS DKCB4 CYS-811 AND TRP-901</scope>
<scope>CHARACTERIZATION OF VARIANTS DKCB4 CYS-811 AND TRP-901</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2007" name="N. Engl. J. Med." volume="356" first="1317" last="1326">
<title>Telomerase mutations in families with idiopathic pulmonary fibrosis.</title>
<authorList>
<person name="Armanios M.Y."/>
<person name="Chen J.J."/>
<person name="Cogan J.D."/>
<person name="Alder J.K."/>
<person name="Ingersoll R.G."/>
<person name="Markin C."/>
<person name="Lawson W.E."/>
<person name="Xie M."/>
<person name="Vulto I."/>
<person name="Phillips J.A."/>
<person name="Lansdorp P.M."/>
<person name="Greider C.W."/>
<person name="Loyd J.E."/>
</authorList>
<dbReference type="PubMed" id="17392301"/>
<dbReference type="DOI" id="10.1056/nejmoa066157"/>
</citation>
<scope>VARIANTS IDIOPATHIC PULMONARY FIBROSIS SUSCEPTIBILITY GLN-55 AND MET-1110</scope>
<scope>CHARACTERIZATION OF VARIANTS GLN-55 AND MET-1110</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="7552" last="7557">
<title>Adult-onset pulmonary fibrosis caused by mutations in telomerase.</title>
<authorList>
<person name="Tsakiri K.D."/>
<person name="Cronkhite J.T."/>
<person name="Kuan P.J."/>
<person name="Xing C."/>
<person name="Raghu G."/>
<person name="Weissler J.C."/>
<person name="Rosenblatt R.L."/>
<person name="Shay J.W."/>
<person name="Garcia C.K."/>
</authorList>
<dbReference type="PubMed" id="17460043"/>
<dbReference type="DOI" id="10.1073/pnas.0701009104"/>
</citation>
<scope>VARIANT PFBMFT1 HIS-865</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2008" name="Blood" volume="111" first="1128" last="1130">
<title>Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene.</title>
<authorList>
<person name="Du H.Y."/>
<person name="Pumbo E."/>
<person name="Manley P."/>
<person name="Field J.J."/>
<person name="Bayliss S.J."/>
<person name="Wilson D.B."/>
<person name="Mason P.J."/>
<person name="Bessler M."/>
</authorList>
<dbReference type="PubMed" id="18042801"/>
<dbReference type="DOI" id="10.1182/blood-2007-10-120907"/>
</citation>
<scope>VARIANTS DKCB4 TYR-412 AND SER-704</scope>
<scope>CHARACTERIZATION OF VARIANTS DKCB4 TYR-412 AND SER-704</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2009" name="Hum. Mutat." volume="30" first="1567" last="1573">
<title>Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia.</title>
<authorList>
<person name="Kirwan M."/>
<person name="Vulliamy T."/>
<person name="Marrone A."/>
<person name="Walne A.J."/>
<person name="Beswick R."/>
<person name="Hillmen P."/>
<person name="Kelly R."/>
<person name="Stewart A."/>
<person name="Bowen D."/>
<person name="Schonland S.O."/>
<person name="Whittle A.M."/>
<person name="McVerry A."/>
<person name="Gilleece M."/>
<person name="Dokal I."/>
</authorList>
<dbReference type="PubMed" id="19760749"/>
<dbReference type="DOI" id="10.1002/humu.21115"/>
</citation>
<scope>VARIANTS ALA-65; MET-299; LYS-522 AND THR-1062</scope>
<scope>VARIANTS AA THR-202; TYR-412; GLU-441 DEL; ASN-570; GLN-631; MET-694 AND LEU-785</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="1187" last="1192">
<title>Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.</title>
<authorList>
<person name="Calado R.T."/>
<person name="Regal J.A."/>
<person name="Hills M."/>
<person name="Yewdell W.T."/>
<person name="Dalmazzo L.F."/>
<person name="Zago M.A."/>
<person name="Lansdorp P.M."/>
<person name="Hogge D."/>
<person name="Chanock S.J."/>
<person name="Estey E.H."/>
<person name="Falcao R.P."/>
<person name="Young N.S."/>
</authorList>
<dbReference type="PubMed" id="19147845"/>
<dbReference type="DOI" id="10.1073/pnas.0807057106"/>
</citation>
<scope>VARIANTS ALA-65; MET-299; TYR-412; GLU-441 DEL; LYS-522 AND THR-1062</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2011" name="Blood" volume="117" first="5607" last="5611">
<title>Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase.</title>
<authorList>
<person name="Parry E.M."/>
<person name="Alder J.K."/>
<person name="Qi X."/>
<person name="Chen J.J."/>
<person name="Armanios M."/>
</authorList>
<dbReference type="PubMed" id="21436073"/>
<dbReference type="DOI" id="10.1182/blood-2010-11-322149"/>
</citation>
<scope>VARIANTS PFBMFT1 MET-170; THR-716; PHE-841; ARG-902 AND PHE-1025</scope>
<scope>CHARACTERIZATION OF VARIANTS PFBMFT1 MET-170; THR-716; PHE-841 AND PHE-1025</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2011" name="Nature" volume="474" first="399" last="402">
<title>Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.</title>
<authorList>
<person name="Batista L.F."/>
<person name="Pech M.F."/>
<person name="Zhong F.L."/>
<person name="Nguyen H.N."/>
<person name="Xie K.T."/>
<person name="Zaug A.J."/>
<person name="Crary S.M."/>
<person name="Choi J."/>
<person name="Sebastiano V."/>
<person name="Cherry A."/>
<person name="Giri N."/>
<person name="Wernig M."/>
<person name="Alter B.P."/>
<person name="Cech T.R."/>
<person name="Savage S.A."/>
<person name="Reijo Pera R.A."/>
<person name="Artandi S.E."/>
</authorList>
<dbReference type="PubMed" id="21602826"/>
<dbReference type="DOI" id="10.1038/nature10084"/>
</citation>
<scope>VARIANT DKCB4 SER-704</scope>
<scope>VARIANT DKCA2 TRP-979</scope>
<scope>CHARACTERIZATION OF VARIANT DKCB4 SER-704</scope>
<scope>CHARACTERIZATION OF VARIANT DKCA2 TRP-979</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2011" name="PLoS Genet." volume="7" first="E1001352" last="E1001352">
<title>Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis.</title>
<authorList>
<person name="Alder J.K."/>
<person name="Cogan J.D."/>
<person name="Brown A.F."/>
<person name="Anderson C.J."/>
<person name="Lawson W.E."/>
<person name="Lansdorp P.M."/>
<person name="Phillips J.A. III"/>
<person name="Loyd J.E."/>
<person name="Chen J.J."/>
<person name="Armanios M."/>
</authorList>
<dbReference type="PubMed" id="21483807"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1001352"/>
</citation>
<scope>VARIANTS PFBMFT1 ILE-791 AND MET-867</scope>
<scope>CHARACTERIZATION OF VARIANTS PFBMFT1 ILE-791 AND MET-867</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2012" name="N. Engl. J. Med." volume="366" first="1551" last="1553">
<title>Pulmonary fibrosis, bone marrow failure, and telomerase mutation.</title>
<authorList>
<person name="Gansner J.M."/>
<person name="Rosas I.O."/>
<person name="Ebert B.L."/>
</authorList>
<dbReference type="PubMed" id="22512499"/>
<dbReference type="DOI" id="10.1056/nejmc1200999"/>
</citation>
<scope>VARIANT PFBMFT1 LEU-923</scope>
</reference>
<comment type="function">
<text evidence="7 9 12 18 19 20 23 29 30 31 33 47">Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. Active in progenitor and cancer cells. Inactive, or very low activity, in normal somatic cells. Catalytic component of the teleromerase holoenzyme complex whose main activity is the elongation of telomeres by acting as a reverse transcriptase that adds simple sequence repeats to chromosome ends by copying a template sequence within the RNA component of the enzyme. Catalyzes the RNA-dependent extension of 3'-chromosomal termini with the 6-nucleotide telomeric repeat unit, 5'-TTAGGG-3'. The catalytic cycle involves primer binding, primer extension and release of product once the template boundary has been reached or nascent product translocation followed by further extension. More active on substrates containing 2 or 3 telomeric repeats. Telomerase activity is regulated by a number of factors including telomerase complex-associated proteins, chaperones and polypeptide modifiers. Modulates Wnt signaling. Plays important roles in aging and antiapoptosis.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="37 45">
<text>a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) = diphosphate + DNA(n+1)</text>
<dbReference type="Rhea" id="RHEA:22508"/>
<dbReference type="Rhea" id="RHEA-COMP:11130"/>
<dbReference type="Rhea" id="RHEA-COMP:11131"/>
<dbReference type="ChEBI" id="CHEBI:33019"/>
<dbReference type="ChEBI" id="CHEBI:61560"/>
<dbReference type="ChEBI" id="CHEBI:83828"/>
<dbReference type="EC" id="2.7.7.49"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="2 5 6 8 10 26 28 30 34 38 39 44 45">Catalytic component of the telomerase holoenzyme complex composed of one molecule of TERT, one molecule of WRAP53/TCAB1, two molecules of H/ACA ribonucleoprotein complex subunits DKC1, NOP10, NHP2 and GAR1, and a telomerase RNA template component (TERC) (PubMed:19179534, PubMed:20351177, PubMed:29695869). The telomerase holoenzyme complex is associated with TEP1, SMG6/EST1A and POT1 (PubMed:19179534). The molecular chaperone HSP90/P23 complex is required for correct assembly and stabilization of the active telomerase (PubMed:11274138). Interacts directly with HSP90A and PTGES3 (PubMed:11274138). Interacts with HSPA1A; the interaction occurs in the absence of TERC and dissociates once the complex has formed (PubMed:11274138). Interacts with RAN; the interaction promotes nuclear export of TERT (PubMed:12808100). Interacts with XPO1 (PubMed:12808100). Interacts with PTPN11; the interaction retains TERT in the nucleus (PubMed:18829466). Interacts with NCL (via RRM1 and C-terminal RRM4/Arg/Gly-rich domains); the interaction is important for nucleolar localization of TERT (PubMed:15371412). Interacts with SMARCA4 (via the bromodomain); the interaction regulates Wnt-mediated signaling (By similarity). Interacts with MCRS1 (isoform MCRS2); the interaction inhibits in vitro telomerase activity (PubMed:15044100). Interacts with PIF1; the interaction has no effect on the elongation activity of TERT (By similarity). Interacts with PML; the interaction recruits TERT to PML bodies and inhibits telomerase activity (PubMed:19567472). Interacts with GNL3L (By similarity). Interacts with isoform 1 and isoform 2 of NVL (PubMed:22226966). Interacts with DHX36 (PubMed:21846770). Interacts with ATF7 (PubMed:29490055).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-641642">
<id>Q9BVP2</id>
<label>GNL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-78579">
<id>P06748</id>
<label>NPM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-721782">
<id>Q96BK5</id>
<label>PINX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-304008">
<id>P29590-5</id>
<label>PML</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-353675">
<id>Q9Y265</id>
<label>RUVBL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-302489">
<id>P51532</id>
<label>SMARCA4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-1772203">
<id>O14746</id>
<label>TERT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-15619703">
<id>O14773-1</id>
<label>TPP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-373471">
<id>Q92900</id>
<label>UPF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1772203">
<id>O14746</id>
</interactant>
<interactant intactId="EBI-1177242">
<id>P03126</id>
<label>E6</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="39">Nucleus</location>
<location evidence="39">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>Nucleoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Chromosome</location>
<location>Telomere</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>PML body</location>
</subcellularLocation>
<text>Shuttling between nuclear and cytoplasm depends on cell cycle, phosphorylation states, transformation and DNA damage. Diffuse localization in the nucleoplasm. Enriched in nucleoli of certain cell types. Translocated to the cytoplasm via nuclear pores in a CRM1/RAN-dependent manner involving oxidative stress-mediated phosphorylation at Tyr-707. Dephosphorylation at this site by SHP2 retains TERT in the nucleus. Translocated to the nucleus by phosphorylation by AKT.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O14746-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O14746-2</id>
<name>2</name>
<sequence type="described" ref="VSP_019587 VSP_019588"/>
</isoform>
<isoform>
<id>O14746-3</id>
<name>3</name>
<sequence type="described" ref="VSP_021727"/>
</isoform>
<isoform>
<id>O14746-4</id>
<name>4</name>
<sequence type="described" ref="VSP_053369 VSP_019587 VSP_019588"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="46 47">Expressed at a high level in thymocyte subpopulations, at an intermediate level in tonsil T-lymphocytes, and at a low to undetectable level in peripheral blood T-lymphocytes.</text>
</comment>
<comment type="induction">
<text evidence="46">Activated by cytotoxic events and down-regulated during aging. In peripheral T-lymphocytes, induced By CD3 and by PMA/ionomycin. Inhibited by herbimycin B.</text>
</comment>
<comment type="domain">
<text>The primer grip sequence in the RT domain is required for telomerase activity and for stable association with short telomeric primers.</text>
</comment>
<comment type="domain">
<text>The RNA-interacting domain 1 (RD1)/N-terminal extension (NTE) is required for interaction with the pseudoknot-template domain of each of TERC dimers. It contains anchor sites that bind primer nucleotides upstream of the RNA-DNA hybrid and is thus an essential determinant of repeat addition processivity.</text>
</comment>
<comment type="domain">
<text>The RNA-interacting domain 2 (RD2) is essential for both interaction with the CR4-CR5 domain of TERC and for DNA synthesis.</text>
</comment>
<comment type="PTM">
<text evidence="6 26 40 43">Phosphorylation at Tyr-707 under oxidative stress leads to translocation of TERT to the cytoplasm and reduces its antiapoptotic activity. Dephosphorylated by SHP2/PTPN11 leading to nuclear retention. Phosphorylation at Ser-227 by the AKT pathway promotes nuclear location. Phosphorylation at the G2/M phase at Ser-457 by DYRK2 promotes ubiquitination by the EDVP complex and degradation.</text>
</comment>
<comment type="PTM">
<text evidence="43">Ubiquitinated by the EDVP complex, a E3 ligase complex following phosphorylation at Ser-457 by DYRK2. Ubiquitinated leads to proteasomal degradation.</text>
</comment>
<comment type="PTM">
<text evidence="43">(Microbial infection) In case of infection by HIV-1, the EDVP complex is hijacked by HIV-1 via interaction between HIV-1 Vpr and DCAF1/VPRBP, leading to ubiquitination and degradation.</text>
</comment>
<comment type="disease">
<text>Activation of telomerase has been implicated in cell immortalization and cancer cell pathogenesis.</text>
</comment>
<comment type="disease" evidence="13 16 17 32">
<disease id="DI-02842">
<name>Aplastic anemia</name>
<acronym>AA</acronym>
<description>A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. It is characterized by peripheral pancytopenia and marrow hypoplasia.</description>
<dbReference type="MIM" id="609135"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>Genetic variations in TERT are associated with coronary artery disease (CAD).</text>
</comment>
<comment type="disease" evidence="13 14 37">
<disease id="DI-00407">
<name>Dyskeratosis congenita, autosomal dominant, 2</name>
<acronym>DKCA2</acronym>
<description>A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy.</description>
<dbReference type="MIM" id="613989"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="11 22 35 36 41">
<disease id="DI-03500">
<name>Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1</name>
<acronym>PFBMFT1</acronym>
<description>A disease associated with shortened telomeres. Pulmonary fibrosis is the most common manifestation. Other manifestations include aplastic anemia due to bone marrow failure, hepatic fibrosis, and increased cancer risk, particularly myelodysplastic syndrome and acute myeloid leukemia. Phenotype, age at onset, and severity are determined by telomere length.</description>
<dbReference type="MIM" id="614742"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="15 24 25 37">
<disease id="DI-03166">
<name>Dyskeratosis congenita, autosomal recessive, 4</name>
<acronym>DKCB4</acronym>
<description>A severe form of dyskeratosis congenita, a rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy.</description>
<dbReference type="MIM" id="613989"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-02670">
<name>Pulmonary fibrosis, idiopathic</name>
<acronym>IPF</acronym>
<description>A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease.</description>
<dbReference type="MIM" id="178500"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="42">
<disease id="DI-03701">
<name>Melanoma, cutaneous malignant 9</name>
<acronym>CMM9</acronym>
<description>A malignant neoplasm of melanocytes, arising de novo or from a pre-existing benign nevus, which occurs most often in the skin but also may involve other sites.</description>
<dbReference type="MIM" id="615134"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 3</molecule>
<text evidence="52">May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</comment>
<comment type="similarity">
<text evidence="52">Belongs to the reverse transcriptase family. Telomerase subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/tert/"/>
</comment>
<dbReference type="EC" id="2.7.7.49" evidence="37 45"/>
<dbReference type="EMBL" id="AF018167">
<property type="protein sequence ID" value="AAC51724.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF015950">
<property type="protein sequence ID" value="AAC51672.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF128894">
<property type="protein sequence ID" value="AAD30037.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF128893">
<property type="protein sequence ID" value="AAD30037.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB085628">
<property type="protein sequence ID" value="BAC11010.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB086379">
<property type="protein sequence ID" value="BAC11014.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB086950">
<property type="protein sequence ID" value="BAC11015.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY007685">
<property type="protein sequence ID" value="AAG23289.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ264729">
<property type="protein sequence ID" value="ABB72674.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC114291">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471102">
<property type="protein sequence ID" value="EAX08167.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3861.2">
<molecule id="O14746-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54831.1">
<molecule id="O14746-3"/>
</dbReference>
<dbReference type="PIR" id="T03844">
<property type="entry name" value="T03844"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180305.1">
<molecule id="O14746-3"/>
<property type="nucleotide sequence ID" value="NM_001193376.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_937983.2">
<molecule id="O14746-1"/>
<property type="nucleotide sequence ID" value="NM_198253.2"/>
</dbReference>
<dbReference type="PDB" id="2BCK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="C/F=461-469"/>
</dbReference>
<dbReference type="PDB" id="4B18">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="B=222-240"/>
</dbReference>
<dbReference type="PDB" id="4MNQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.74"/>
<property type="chains" value="C=540-548"/>
</dbReference>
<dbReference type="PDB" id="5MEN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="C=540-548"/>
</dbReference>
<dbReference type="PDB" id="5MEO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="C=540-548"/>
</dbReference>
<dbReference type="PDB" id="5MEP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="C/F=540-548"/>
</dbReference>
<dbReference type="PDB" id="5MEQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="C=540-546"/>
</dbReference>
<dbReference type="PDB" id="5MER">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.88"/>
<property type="chains" value="C/F=540-546"/>
</dbReference>
<dbReference type="PDB" id="5UGW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A=961-1132"/>
</dbReference>
<dbReference type="PDBsum" id="2BCK"/>
<dbReference type="PDBsum" id="4B18"/>
<dbReference type="PDBsum" id="4MNQ"/>
<dbReference type="PDBsum" id="5MEN"/>
<dbReference type="PDBsum" id="5MEO"/>
<dbReference type="PDBsum" id="5MEP"/>
<dbReference type="PDBsum" id="5MEQ"/>
<dbReference type="PDBsum" id="5MER"/>
<dbReference type="PDBsum" id="5UGW"/>
<dbReference type="SMR" id="O14746"/>
<dbReference type="BioGRID" id="112874">
<property type="interactions" value="98"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-17">
<property type="entry name" value="Telomerase catalytic core complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-20">
<property type="entry name" value="TERT-RMRP complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-265">
<property type="entry name" value="Telomerase holoenzyme complex"/>
</dbReference>
<dbReference type="CORUM" id="O14746"/>
<dbReference type="DIP" id="DIP-40646N"/>
<dbReference type="ELM" id="O14746"/>
<dbReference type="IntAct" id="O14746">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="MINT" id="O14746"/>
<dbReference type="STRING" id="9606.ENSP00000309572"/>
<dbReference type="BindingDB" id="O14746"/>
<dbReference type="ChEMBL" id="CHEMBL2916"/>
<dbReference type="DrugBank" id="DB05036">
<property type="generic name" value="Grn163l"/>
</dbReference>
<dbReference type="DrugBank" id="DB12747">
<property type="generic name" value="Tertomotide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00495">
<property type="generic name" value="Zidovudine"/>
</dbReference>
<dbReference type="DrugCentral" id="O14746"/>
<dbReference type="iPTMnet" id="O14746"/>
<dbReference type="PhosphoSitePlus" id="O14746"/>
<dbReference type="BioMuta" id="TERT"/>
<dbReference type="EPD" id="O14746"/>
<dbReference type="MassIVE" id="O14746"/>
<dbReference type="PaxDb" id="O14746"/>
<dbReference type="PeptideAtlas" id="O14746"/>
<dbReference type="PRIDE" id="O14746"/>
<dbReference type="ProteomicsDB" id="48203">
<molecule id="O14746-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48204">
<molecule id="O14746-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48205">
<molecule id="O14746-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="73418"/>
<dbReference type="ABCD" id="O14746">
<property type="antibodies" value="9 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="8998">
<property type="antibodies" value="943 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7015"/>
<dbReference type="Ensembl" id="ENST00000310581">
<molecule id="O14746-1"/>
<property type="protein sequence ID" value="ENSP00000309572"/>
<property type="gene ID" value="ENSG00000164362"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000334602">
<molecule id="O14746-3"/>
<property type="protein sequence ID" value="ENSP00000334346"/>
<property type="gene ID" value="ENSG00000164362"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000460137">
<molecule id="O14746-4"/>
<property type="protein sequence ID" value="ENSP00000425003"/>
<property type="gene ID" value="ENSG00000164362"/>
</dbReference>
<dbReference type="GeneID" id="7015"/>
<dbReference type="KEGG" id="hsa:7015"/>
<dbReference type="UCSC" id="uc003jcb.2">
<molecule id="O14746-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7015"/>
<dbReference type="DisGeNET" id="7015"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000164362.18"/>
<dbReference type="GeneCards" id="TERT"/>
<dbReference type="GeneReviews" id="TERT"/>
<dbReference type="HGNC" id="HGNC:11730">
<property type="gene designation" value="TERT"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000164362">
<property type="expression patterns" value="Group enriched (bone marrow, lymphoid tissue, testis)"/>
</dbReference>
<dbReference type="MalaCards" id="TERT"/>
<dbReference type="MIM" id="178500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="187270">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="MIM" id="609135">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613989">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614742">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="615134">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O14746"/>
<dbReference type="OpenTargets" id="ENSG00000164362"/>
<dbReference type="Orphanet" id="457246">
<property type="disease" value="Clear cell sarcoma of kidney"/>
</dbReference>
<dbReference type="Orphanet" id="146">
<property type="disease" value="Differentiated thyroid carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="1775">
<property type="disease" value="Dyskeratosis congenita"/>
</dbReference>
<dbReference type="Orphanet" id="618">
<property type="disease" value="Familial melanoma"/>
</dbReference>
<dbReference type="Orphanet" id="3322">
<property type="disease" value="Hoyeraal-Hreidarsson syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="88">
<property type="disease" value="Idiopathic aplastic anemia"/>
</dbReference>
<dbReference type="Orphanet" id="2032">
<property type="disease" value="Idiopathic pulmonary fibrosis"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36447"/>
<dbReference type="eggNOG" id="KOG1005">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000018531"/>
<dbReference type="HOGENOM" id="CLU_001996_2_0_1"/>
<dbReference type="InParanoid" id="O14746"/>
<dbReference type="KO" id="K11126"/>
<dbReference type="OMA" id="HCAPHRV"/>
<dbReference type="OrthoDB" id="1297956at2759"/>
<dbReference type="PhylomeDB" id="O14746"/>
<dbReference type="TreeFam" id="TF329048"/>
<dbReference type="PathwayCommons" id="O14746"/>
<dbReference type="Reactome" id="R-HSA-171319">
<property type="pathway name" value="Telomere Extension By Telomerase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-201722">
<property type="pathway name" value="Formation of the beta-catenin:TCF transactivating complex"/>
</dbReference>
<dbReference type="SIGNOR" id="O14746"/>
<dbReference type="BioGRID-ORCS" id="7015">
<property type="hits" value="16 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O14746"/>
<dbReference type="GeneWiki" id="Telomerase_reverse_transcriptase"/>
<dbReference type="GenomeRNAi" id="7015"/>
<dbReference type="Pharos" id="O14746">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:O14746"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="O14746">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000164362">
<property type="expression patterns" value="Expressed in stromal cell of endometrium and 152 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="O14746">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000781">
<property type="term" value="C:chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0042645">
<property type="term" value="C:mitochondrial nucleoid"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000784">
<property type="term" value="C:nuclear chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000783">
<property type="term" value="C:nuclear telomere cap complex"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0031379">
<property type="term" value="C:RNA-directed RNA polymerase complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000333">
<property type="term" value="C:telomerase catalytic core complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005697">
<property type="term" value="C:telomerase holoenzyme complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990572">
<property type="term" value="C:TERT-RMRP complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051087">
<property type="term" value="F:chaperone binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0047485">
<property type="term" value="F:protein N-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003968">
<property type="term" value="F:RNA-directed 5'-3' RNA polymerase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003964">
<property type="term" value="F:RNA-directed DNA polymerase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003720">
<property type="term" value="F:telomerase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070034">
<property type="term" value="F:telomerase RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003721">
<property type="term" value="F:telomerase RNA reverse transcriptase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042162">
<property type="term" value="F:telomeric DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0098680">
<property type="term" value="F:template-free RNA nucleotidyltransferase"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001223">
<property type="term" value="F:transcription coactivator binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000049">
<property type="term" value="F:tRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904837">
<property type="term" value="P:beta-catenin-TCF complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071897">
<property type="term" value="P:DNA biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0022616">
<property type="term" value="P:DNA strand elongation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0062103">
<property type="term" value="P:double-stranded RNA biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070200">
<property type="term" value="P:establishment of protein localization to telomere"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007005">
<property type="term" value="P:mitochondrion organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000773">
<property type="term" value="P:negative regulation of cellular senescence"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000352">
<property type="term" value="P:negative regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001240">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903704">
<property type="term" value="P:negative regulation of production of siRNA involved in RNA interference"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900087">
<property type="term" value="P:positive regulation of G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046326">
<property type="term" value="P:positive regulation of glucose import"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042635">
<property type="term" value="P:positive regulation of hair cycle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051000">
<property type="term" value="P:positive regulation of nitric-oxide synthase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902895">
<property type="term" value="P:positive regulation of pri-miRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032092">
<property type="term" value="P:positive regulation of protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904751">
<property type="term" value="P:positive regulation of protein localization to nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000648">
<property type="term" value="P:positive regulation of stem cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903620">
<property type="term" value="P:positive regulation of transdifferentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904754">
<property type="term" value="P:positive regulation of vascular associated smooth muscle cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904707">
<property type="term" value="P:positive regulation of vascular associated smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030177">
<property type="term" value="P:positive regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030422">
<property type="term" value="P:production of siRNA involved in RNA interference"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031647">
<property type="term" value="P:regulation of protein stability"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090399">
<property type="term" value="P:replicative senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046686">
<property type="term" value="P:response to cadmium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006278">
<property type="term" value="P:RNA-dependent DNA biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000723">
<property type="term" value="P:telomere maintenance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007004">
<property type="term" value="P:telomere maintenance via telomerase"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001172">
<property type="term" value="P:transcription, RNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="InterPro" id="IPR043502">
<property type="entry name" value="DNA/RNA_pol_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000477">
<property type="entry name" value="RT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR021891">
<property type="entry name" value="Telomerase_RBD"/>
</dbReference>
<dbReference type="InterPro" id="IPR003545">
<property type="entry name" value="Telomerase_RT"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR12066">
<property type="entry name" value="PTHR12066"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00078">
<property type="entry name" value="RVT_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12009">
<property type="entry name" value="Telomerase_RBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01365">
<property type="entry name" value="TELOMERASERT"/>
</dbReference>
<dbReference type="SMART" id="SM00975">
<property type="entry name" value="Telomerase_RBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56672">
<property type="entry name" value="SSF56672"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50878">
<property type="entry name" value="RT_POL"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1011">Dyskeratosis congenita</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0548">Nucleotidyltransferase</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0687">Ribonucleoprotein</keyword>
<keyword id="KW-0695">RNA-directed DNA polymerase</keyword>
<keyword id="KW-0779">Telomere</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Telomerase reverse transcriptase" id="PRO_0000054925">
<location>
<begin position="1"/>
<end position="1132"/>
</location>
</feature>
<feature type="domain" description="Reverse transcriptase" evidence="4">
<location>
<begin position="605"/>
<end position="935"/>
</location>
</feature>
<feature type="region of interest" description="RNA-interacting domain 1">
<location>
<begin position="1"/>
<end position="230"/>
</location>
</feature>
<feature type="region of interest" description="GQ motif">
<location>
<begin position="58"/>
<end position="197"/>
</location>
</feature>
<feature type="region of interest" description="Required for regulating specificity for telomeric DNA and for processivity for primer elongation">
<location>
<begin position="137"/>
<end position="141"/>
</location>
</feature>
<feature type="region of interest" description="Linker">
<location>
<begin position="231"/>
<end position="324"/>
</location>
</feature>
<feature type="region of interest" description="Required for oligomerization">
<location>
<begin position="301"/>
<end position="538"/>
</location>
</feature>
<feature type="region of interest" description="RNA-interacting domain 2">
<location>
<begin position="325"/>
<end position="550"/>
</location>
</feature>
<feature type="region of interest" description="QFP motif">
<location>
<begin position="376"/>
<end position="521"/>
</location>
</feature>
<feature type="region of interest" description="CP motif">
<location>
<begin position="397"/>
<end position="417"/>
</location>
</feature>
<feature type="region of interest" description="Required for oligomerization">
<location>
<begin position="914"/>
<end position="928"/>
</location>
</feature>
<feature type="region of interest" description="Primer grip sequence">
<location>
<begin position="930"/>
<end position="934"/>
</location>
</feature>
<feature type="region of interest" description="CTE">
<location>
<begin position="936"/>
<end position="1132"/>
</location>
</feature>
<feature type="short sequence motif" description="Bipartite nuclear localization signal">
<location>
<begin position="222"/>
<end position="240"/>
</location>
</feature>
<feature type="short sequence motif" description="TFLY; involved in RNA binding" evidence="3">
<location>
<begin position="328"/>
<end position="333"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium; catalytic" evidence="4">
<location>
<position position="712"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium; catalytic" evidence="4">
<location>
<position position="868"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium; catalytic" evidence="4">
<location>
<position position="869"/>
</location>
</feature>
<feature type="site" description="Required for optimal binding of telomeric ssDNA and incorporation of nucleotides at the second position of the template">
<location>
<position position="169"/>
</location>
</feature>
<feature type="site" description="Required for nucleotide incorporation and primer extension rate">
<location>
<position position="867"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB/AKT1" evidence="40">
<location>
<position position="227"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DYRK2" evidence="43">
<location>
<position position="457"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC-type Tyr-kinases" evidence="6 26">
<location>
<position position="707"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_053369" evidence="51">
<location>
<begin position="711"/>
<end position="722"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_019587" evidence="50 51">
<original>STLTDLQPYMRQFVAHLQETSPLRDAVVIEQSSSLNEASSGLFD</original>
<variation>LRPVPGDPAGLHPLHAALQPVLRRHGEQAVCGDSAGRAAPAFGG</variation>
<location>
<begin position="764"/>
<end position="807"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_019588" evidence="50 51">
<location>
<begin position="808"/>
<end position="1132"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_021727" evidence="51">
<location>
<begin position="885"/>
<end position="947"/>
</location>
</feature>
<feature type="sequence variant" description="In idiopathic pulmonary fibrosis susceptibility; impaired telomerase activity; dbSNP:rs387907247." id="VAR_062535" evidence="21">
<original>L</original>
<variation>Q</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" description="Associated with acute myeloid leukemia; dbSNP:rs544215765." id="VAR_062780" evidence="27 32">
<original>P</original>
<variation>A</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1; the mutant protein is demonstrated to cause decreased telomerase activity; dbSNP:rs387907248." id="VAR_068792" evidence="35">
<original>V</original>
<variation>M</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1 and AA; severe and moderate; associated with disease susceptibility; shorter telomeres; dbSNP:rs121918661." id="VAR_036863" evidence="11 13 32">
<original>A</original>
<variation>T</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs61748181." id="VAR_036864" evidence="11">
<original>A</original>
<variation>T</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="Associated with acute myeloid leukemia; dbSNP:rs756624928." id="VAR_062781" evidence="27 32">
<original>V</original>
<variation>M</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1, AA and DKCB4; severe and moderate; associated with susceptibility to acute myelogenous leukemia; the mutant protein has 36% residual activity; dbSNP:rs34094720." id="VAR_025149" evidence="11 25 27 32 49">
<original>H</original>
<variation>Y</variation>
<location>
<position position="412"/>
</location>
</feature>
<feature type="sequence variant" description="In AA; associated with susceptibility to acute myeloid leukemia." id="VAR_036865" evidence="11 27 32">
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="Associated with acute myeloid leukemia." id="VAR_062782" evidence="27 32">
<original>R</original>
<variation>K</variation>
<location>
<position position="522"/>
</location>
</feature>
<feature type="sequence variant" description="In AA; abolishes telomerase catalytic activity but no effect on binding to TERC." id="VAR_062536" evidence="17 32">
<original>K</original>
<variation>N</variation>
<location>
<position position="570"/>
</location>
</feature>
<feature type="sequence variant" description="In AA; dbSNP:rs199422294." id="VAR_062783" evidence="32">
<original>R</original>
<variation>Q</variation>
<location>
<position position="631"/>
</location>
</feature>
<feature type="sequence variant" description="In AA; non-severe; abolishes telomerase catalytic activity but little effect on binding to TERC; dbSNP:rs199422295." id="VAR_062537" evidence="16 17">
<original>G</original>
<variation>D</variation>
<location>
<position position="682"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1 and AA; moderate; dbSNP:rs121918662." id="VAR_036866" evidence="11 32">
<original>V</original>
<variation>M</variation>
<location>
<position position="694"/>
</location>
</feature>
<feature type="sequence variant" description="In DKCB4; the mutant protein has 13% residual activity; dbSNP:rs199422297." id="VAR_068793" evidence="25 37">
<original>P</original>
<variation>S</variation>
<location>
<position position="704"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1; the mutant protein is demonstrated to cause severely compromised telomerase activity; dbSNP:rs387907249." id="VAR_068794" evidence="35">
<original>A</original>
<variation>T</variation>
<location>
<position position="716"/>
</location>
</feature>
<feature type="sequence variant" description="In DKCB4; no effect on telomerase catalytic activity and little effect on binding to TERC; dbSNP:rs199422299." id="VAR_062538" evidence="15 17">
<original>P</original>
<variation>R</variation>
<location>
<position position="721"/>
</location>
</feature>
<feature type="sequence variant" description="In AA; very severe; no effect on telomerase catalytic activity but shortened telomeres; dbSNP:rs149566858." id="VAR_062539" evidence="16 17">
<original>T</original>
<variation>M</variation>
<location>
<position position="726"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1; moderate; dbSNP:rs121918663." id="VAR_036867" evidence="11">
<original>Y</original>
<variation>C</variation>
<location>
<position position="772"/>
</location>
</feature>
<feature type="sequence variant" description="In AA; dbSNP:rs483352771." id="VAR_062784" evidence="32">
<original>P</original>
<variation>L</variation>
<location>
<position position="785"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1; associated with Met-867 in cis on the same allele; the double mutant shows severe defects in telomere repeat addition processivity; dbSNP:rs141425941." id="VAR_068795" evidence="36">
<original>V</original>
<variation>I</variation>
<location>
<position position="791"/>
</location>
</feature>
<feature type="sequence variant" description="In DKCB4; 50% reduction in telomerase activity; dbSNP:rs199422301." id="VAR_062540" evidence="24">
<original>R</original>
<variation>C</variation>
<location>
<position position="811"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1." id="VAR_068796" evidence="35">
<original>L</original>
<variation>F</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1; dbSNP:rs121918666." id="VAR_036868" evidence="22">
<original>R</original>
<variation>H</variation>
<location>
<position position="865"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1; associated with Ile-791 in cis on the same allele; the double mutant shows severe defects in telomere repeat addition processivity; this mutation causes most if not all of the functional defects; dbSNP:rs201159197." id="VAR_068797" evidence="36">
<original>V</original>
<variation>M</variation>
<location>
<position position="867"/>
</location>
</feature>
<feature type="sequence variant" description="In DKCB4; severe phenotype overlapping with Hoyeraal-Hreidarsson syndrome; very short telomeres and greatly reduced telomerase activity; dbSNP:rs199422304." id="VAR_062541" evidence="24">
<original>R</original>
<variation>W</variation>
<location>
<position position="901"/>
</location>
</feature>
<feature type="sequence variant" description="In DKCA2; abolishes telomerase catalytic activity but no effect on binding to TERC; dbSNP:rs121918665." id="VAR_036869" evidence="14 17">
<original>K</original>
<variation>N</variation>
<location>
<position position="902"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1; dbSNP:rs387907250." id="VAR_068798" evidence="35">
<original>K</original>
<variation>R</variation>
<location>
<position position="902"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1; dbSNP:rs387907251." id="VAR_068799" evidence="41">
<original>P</original>
<variation>L</variation>
<location>
<position position="923"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34062885." id="VAR_053726">
<original>S</original>
<variation>R</variation>
<location>
<position position="948"/>
</location>
</feature>
<feature type="sequence variant" description="In DKCA2; shortened telomeres but no effect on telomerase catalytic activity nor on binding to TERC; dbSNP:rs199422305." id="VAR_062542" evidence="13 17 37">
<original>R</original>
<variation>W</variation>
<location>
<position position="979"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1." id="VAR_068800" evidence="35">
<original>V</original>
<variation>F</variation>
<location>
<position position="1025"/>
</location>
</feature>
<feature type="sequence variant" description="Increased incidence in sporadic acute myeloid leukemia; dbSNP:rs35719940." id="VAR_025150" evidence="11 27 32 49">
<original>A</original>
<variation>T</variation>
<location>
<position position="1062"/>
</location>
</feature>
<feature type="sequence variant" description="In PFBMFT1; severe; dbSNP:rs121918664." id="VAR_036870" evidence="11">
<original>V</original>
<variation>M</variation>
<location>
<position position="1090"/>
</location>
</feature>
<feature type="sequence variant" description="In idiopathic pulmonary fibrosis susceptibility; impaired telomerase activity; dbSNP:rs199422306." id="VAR_062543" evidence="21">
<original>T</original>
<variation>M</variation>
<location>
<position position="1110"/>
</location>
</feature>
<feature type="sequence variant" description="In DKCA2; severe; shortened telomeres but no effect on telomerase catalytic activity nor on binding to TERC; dbSNP:rs1176273130." id="VAR_062544" evidence="13 17">
<original>F</original>
<variation>L</variation>
<location>
<position position="1127"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced catalytic activity and repeat addition processivity. Complete loss of catalytic activity but no loss of binding to telomeric primers; when associated with 930-A--A-934." evidence="20">
<original>WGLLL</original>
<variation>AAAAA</variation>
<location>
<begin position="137"/>
<end position="141"/>
</location>
</feature>
<feature type="mutagenesis site" description="About 80% loss of enzymatic activity. Greatly reduced incorporation of second nucleotide. Altered strength of binding to ssDNA. Little effect on repeat addition processivity, nor on TR interaction nor on protein levels." evidence="33">
<original>Q</original>
<variation>A</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="mutagenesis site" description="About 85% loss of enzymatic activity. Greatly reduced incorporation of second nucleotide. Altered strength of binding to ssDNA. No effect on protein levels nor on TR interaction." evidence="33">
<original>Q</original>
<variation>N</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="mutagenesis site" description="About 90% loss of enzymatic activity. Greatly reduced incorporation of second nucleotide. Altered strength of binding to ssDNA. No effect on protein levels nor on TR interaction." evidence="33">
<original>Q</original>
<variation>T</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by DYRK2." evidence="43">
<original>S</original>
<variation>A</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="mutagenesis site" description="Defective in high-affinity TERC interactions." evidence="9">
<original>W</original>
<variation>A</variation>
<location>
<position position="547"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes telomerase catalytic activity." evidence="18">
<original>R</original>
<variation>A</variation>
<location>
<position position="631"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes oxidative stress-induced phosphorylation and RAN binding. Impaired nuclear export and enhanced antiapoptotic activity against ROS-dependent apoptosis induction. Impaired interaction with PTPN11. No dephosphorylation by PTPN11." evidence="6 26">
<original>Y</original>
<variation>F</variation>
<location>
<position position="707"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of telomerase activity. In the absence of TR, no loss of binding to telomeric primers." evidence="18 20 47 48">
<original>D</original>
<variation>A</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderate reduction in telomerase activity, no change in repeat extension rate nor on nucleotide incorporation fidelity. Little further reduction in activity but 13.5-fold increase in nucleotide incorporation fidelity; when associated with M-867." evidence="19">
<original>L</original>
<variation>Y</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="mutagenesis site" description="About 75% reduction in telomerase activity, about 80% reduction in repeat reduction rate and 3.9-fold increase in nucleotide incorporation fidelity." evidence="19">
<original>V</original>
<variation>A</variation>
<location>
<position position="867"/>
</location>
</feature>
<feature type="mutagenesis site" description="About 75% reduction in telomerase activity, about 50% reduction in repeat extension rate and 5.2-fold increase in nucleotide incorporation fidelity. Little further reduction in activity and 13.5-fold increase in nucleotide incorporation fidelity; when associated with Y-866." evidence="19">
<original>V</original>
<variation>M</variation>
<location>
<position position="867"/>
</location>
</feature>
<feature type="mutagenesis site" description="Severe reduction in telomerase activity, about 50% reduction in repeat extension rate and 2.2-fold increase in nucleotide incorporation fidelity. No further reduction in activity but 2.8-fold increase in nucleotide incorporation fidelity; when associated with Y-866." evidence="19">
<original>V</original>
<variation>T</variation>
<location>
<position position="867"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of telomerase activity.">
<original>DD</original>
<variation>AA</variation>
<location>
<begin position="868"/>
<end position="869"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of telomerase activity." evidence="9 12 18 47 48">
<original>D</original>
<variation>A</variation>
<location>
<position position="868"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of telomerase activity." evidence="47 48">
<original>D</original>
<variation>A</variation>
<location>
<position position="869"/>
</location>
</feature>
<feature type="mutagenesis site" description="Completely abolishes telomerase-mediated primer extension and reduced binding to short telomeric primers. Complete loss of catalytic activity but no further loss of binding to telomeric primers; when associated with 137-A--A-141." evidence="20">
<original>WCGLL</original>
<variation>AAAAA</variation>
<location>
<begin position="930"/>
<end position="934"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC51724." ref="1" evidence="52">
<original>D</original>
<variation>G</variation>
<location>
<position position="516"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="966"/>
<end position="983"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="984"/>
<end position="986"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="989"/>
<end position="991"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="994"/>
<end position="1017"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1025"/>
<end position="1027"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1029"/>
<end position="1050"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1051"/>
<end position="1053"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1067"/>
<end position="1082"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1083"/>
<end position="1085"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1086"/>
<end position="1104"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1111"/>
<end position="1118"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UGW"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O70372"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q4KTA7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00405"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11274138"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12808100"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14963003"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15044100"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15082768"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15371412"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15814878"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15857955"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15885610"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16247010"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16332973"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16627250"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16990594"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17026956"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17264120"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17296728"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17392301"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17460043"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17548608"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17785587"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18042801"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18829466"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19147845"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19179534"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19188162"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19567472"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19571879"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19760749"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19777057"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20351177"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21436073"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21483807"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21602826"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21846770"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22226966"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22366458"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22512499"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23348503"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23362280"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29490055"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29695869"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8676067"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9389643"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9443919"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="50" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12869302"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14654914"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000305"/>
<sequence length="1132" mass="126997" checksum="94E35469C4CA33A0" modified="1998-01-01" version="1">MPRAPRCRAVRSLLRSHYREVLPLATFVRRLGPQGWRLVQRGDPAAFRALVAQCLVCVPWDARPPPAAPSFRQVSCLKELVARVLQRLCERGAKNVLAFGFALLDGARGGPPEAFTTSVRSYLPNTVTDALRGSGAWGLLLRRVGDDVLVHLLARCALFVLVAPSCAYQVCGPPLYQLGAATQARPPPHASGPRRRLGCERAWNHSVREAGVPLGLPAPGARRRGGSASRSLPLPKRPRRGAAPEPERTPVGQGSWAHPGRTRGPSDRGFCVVSPARPAEEATSLEGALSGTRHSHPSVGRQHHAGPPSTSRPPRPWDTPCPPVYAETKHFLYSSGDKEQLRPSFLLSSLRPSLTGARRLVETIFLGSRPWMPGTPRRLPRLPQRYWQMRPLFLELLGNHAQCPYGVLLKTHCPLRAAVTPAAGVCAREKPQGSVAAPEEEDTDPRRLVQLLRQHSSPWQVYGFVRACLRRLVPPGLWGSRHNERRFLRNTKKFISLGKHAKLSLQELTWKMSVRDCAWLRRSPGVGCVPAAEHRLREEILAKFLHWLMSVYVVELLRSFFYVTETTFQKNRLFFYRKSVWSKLQSIGIRQHLKRVQLRELSEAEVRQHREARPALLTSRLRFIPKPDGLRPIVNMDYVVGARTFRREKRAERLTSRVKALFSVLNYERARRPGLLGASVLGLDDIHRAWRTFVLRVRAQDPPPELYFVKVDVTGAYDTIPQDRLTEVIASIIKPQNTYCVRRYAVVQKAAHGHVRKAFKSHVSTLTDLQPYMRQFVAHLQETSPLRDAVVIEQSSSLNEASSGLFDVFLRFMCHHAVRIRGKSYVQCQGIPQGSILSTLLCSLCYGDMENKLFAGIRRDGLLLRLVDDFLLVTPHLTHAKTFLRTLVRGVPEYGCVVNLRKTVVNFPVEDEALGGTAFVQMPAHGLFPWCGLLLDTRTLEVQSDYSSYARTSIRASLTFNRGFKAGRNMRRKLFGVLRLKCHSLFLDLQVNSLQTVCTNIYKILLLQAYRFHACVLQLPFHQQVWKNPTFFLRVISDTASLCYSILKAKNAGMSLGAKGAAGPLPSEAVQWLCHQAFLLKLTRHRVTYVPLLGSLRTAQTQLSRKLPGTTLTALEAAANPALPSDFKTILD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

